These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 36651010)
1. A case of bullous pemphigoid developing after ixekizumab therapy for pityriasis rubra pilaris. Sugihara N; Kamiya K; Nakano N; Suzuki M; Maekawa T; Murata S; Komine M; Ohtsuki M J Dermatol; 2023 Jun; 50(6):e185-e186. PubMed ID: 36651010 [No Abstract] [Full Text] [Related]
2. Coincidence of Bullous Pemphigoid and Pityriasis Rubra Pilaris. Gasslitter I; Löffler-Ragg J; Schmidt E; Schmuth M; Gruber R Acta Derm Venereol; 2022 Mar; 102():adv00674. PubMed ID: 35170740 [No Abstract] [Full Text] [Related]
3. Evaluation of Ixekizumab Treatment for Patients With Pityriasis Rubra Pilaris: A Single-Arm Trial. Haynes D; Strunck JL; Topham CA; Ortega-Loayza AG; Kent G; Cassidy PB; Hu R; Choate K; Wang Z; Liu Y; Greiling TM JAMA Dermatol; 2020 Jun; 156(6):668-675. PubMed ID: 32293641 [TBL] [Abstract][Full Text] [Related]
4. Successful treatment of resistant pityriasis rubra pilaris with ixekizumab. Penalba-Torres M; Pinilla-Martín B; Aragón-Miguel R; Velasco-Tamariz V; Rivera-Díaz R Dermatol Ther; 2020 Jul; 33(4):e13644. PubMed ID: 32441433 [No Abstract] [Full Text] [Related]
5. A case of pityriasis rubra pilaris treated with tofacitinib after failure with acitretin and ixekizumab. Ying Y; Yu-Hua L; Xiao-Yan W; Su-Chun H Australas J Dermatol; 2023 Aug; 64(3):445-447. PubMed ID: 37200390 [No Abstract] [Full Text] [Related]
11. Successful treatment of TNFα inhibitor-resistant pityriasis rubra pilaris with ixekizumab and acitretin. Chastagner M; Hoelt P; Kanitakis J; Jullien D; Villani AP Eur J Dermatol; 2019 Apr; 29(2):218-220. PubMed ID: 30827945 [No Abstract] [Full Text] [Related]
12. Bullous erythroderma: novel association of pityriasis rubra pilaris with bullous pemphigoid. Genovese G; Muratori S; Berti E; Marzano AV Clin Exp Dermatol; 2019 Jan; 44(1):73-75. PubMed ID: 30129048 [No Abstract] [Full Text] [Related]
13. Successful treatment of pityriasis rubra pilaris with guselkumab: Serum CCL20 as a potential marker for the disease activity. Nagai H; Jimbo H; Matsuura S; Tatsuoka S; Shiraki E; Nishigori C Dermatol Ther; 2020 Nov; 33(6):e14403. PubMed ID: 33044038 [No Abstract] [Full Text] [Related]
14. Pityriasis rubra pilaris: a review of diagnosis and treatment. Cohen PR; Prystowsky JH J Am Acad Dermatol; 1989 May; 20(5 Pt 1):801-7. PubMed ID: 2654219 [TBL] [Abstract][Full Text] [Related]
15. Methotrexate treatment in a case of juvenile pityriasis rubra pilaris. Boyd AH; Polcari IC Pediatr Dermatol; 2018 Jan; 35(1):e62-e63. PubMed ID: 29044698 [TBL] [Abstract][Full Text] [Related]
16. Pityriasis rubra pilaris heralding diagnosis of urothelial carcinoma: a case report. Young PA; Rangel J; Keller LC Dermatol Online J; 2022 Aug; 28(4):. PubMed ID: 36259857 [TBL] [Abstract][Full Text] [Related]
17. Pityriasis rubra pilaris: treatment with biologics - a new promising therapy? Ivanova K; Itin P; Haeusermann P Dermatology; 2012; 224(2):120-5. PubMed ID: 22508269 [TBL] [Abstract][Full Text] [Related]
18. Dupilumab for the treatment of pembrolizumab-induced bullous pemphigoid: A case report. Pop SR; Strock D; Smith RJ Dermatol Ther; 2022 Aug; 35(8):e15623. PubMed ID: 35669992 [No Abstract] [Full Text] [Related]
19. Azathioprine for use in dermatology. Gendler E J Dermatol Surg Oncol; 1984 Jun; 10(6):462-4. PubMed ID: 6725741 [No Abstract] [Full Text] [Related]